EPISODE · Oct 13, 2020 · 33 MIN
BlackRock’s Larry Fink; Johnson & Johnson’s Vaccine Study
from Squawk Pod · host CNBC
Larry Fink, co-founder, Chairman, and CEO of BlackRock, gives his outlook for the markets, the U.S. economic recovery, and fiscal stimulus. For the second time, BlackRock, the world’s largest money manager, is working with the Federal Reserve to help prop up the American economy. Larry Fink considers the promise of SPACs and retail investing platforms like Robinhood, and he underscores the role corporations can play in curbing climate change. Plus, Johnson & Johnson’s Covid vaccine study is paused after a participant reported an illness. Dr. Zeke Emanuel, former White House Health Care Policy Advisor to President Obama, explains that pauses are part of standard scientific inquiry. In a new research letter for the Journal of the American Medical Association, Dr. Emanuel compares America’s response to the pandemic with other similarly populated OECD countries. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Larry Fink, co-founder, Chairman, and CEO of BlackRock, gives his outlook for the markets, the U.S. economic recovery, and fiscal stimulus. For the second time, BlackRock, the world’s largest money manager, is working with the Federal Reserve to help prop up the American economy. Larry Fink considers the promise of SPACs and retail investing platforms like Robinhood, and he underscores the role corporations can play in curbing climate change. Plus, Johnson & Johnson’s Covid vaccine study is paused after a participant reported an illness. Dr. Zeke Emanuel, former White House Health Care Policy Advisor to President Obama, explains that pauses are part of standard scientific inquiry. In a new research letter for the Journal of the American Medical Association, Dr. Emanuel compares America’s response to the pandemic with other similarly populated OECD countries.
NOW PLAYING
BlackRock’s Larry Fink; Johnson & Johnson’s Vaccine Study
No transcript for this episode yet
Similar Episodes
Mar 14, 2026 ·23m
Mar 11, 2026 ·16m
Feb 28, 2026 ·14m